[1]. Hall, M. N. (2013). " Talks about TORCs: Recent Advances in Target of Rapamycin Signalling", Biochemical Society Transactions, Vol. 41, No. 4. PP. 887–8.
[2]. Sharp, Z. D. Nelson, J. F. and Strong R. (2013). "mTOR, Aging and the Potential for Intervention", Experimental Medicine, Vol. 31, No. 20. PP. 1–12.
[3]. Laplante, M. and Sabatini, D. M. (2012). "mTOR Signaling in Growth Control and Disease",Cell, Vol. 149, No. 2. PP. 274–293.
[4]. Dibble, C. C. and Manning, B. D. (2013). "Signal Integration by mTORC1 Coordinates Nutrient Input with Biosynthetic Output", Nature Cell Biology, Vol. 15, No. 6. PP. 555–64.
[5]. Laplante, M. and Sabatini, D. M. (2009). "mTOR Signaling at a Glance", Journal of Cell Science, Vol. 122, No. 20. PP. 3589–94.
[6]. Shimobayashi, M. and Hall, M. N. (2014). "Making New Contacts: the mTOR Network in Metabolism and Signalling Crosstalk", Nature Reviews Molecular Cell Biololgy, Vol. 15, No. 3. PP. 155–62.
[7]. Alayev, A. and Holz, M. K. (2013). "mTOR Signaling for Biological Control and Cancer", Journal of Cell Physiology, Vol. 228, No. 8. PP. 1658–64.
[8].Zoncu, R., Efeyan, A. and Sabatini, D. M. (2011). "mTOR: from Growth Signal Integration to Cancer,Diabetes and Ageing", Nature Reviews Molecular Cell Biololgy, Vol. 12, No. 1. PP. 21–35.
[9].Dann, S. G., Selvaraj, A., and Thomas, G. (2007)."mTOR Complex1-S6K1 Signaling: at the Crossroads of Obesity, Diabetes and Cancer", Trends in Molecular Medicine, Vol. 13, No. 6, PP. 252–9.
[10].Dunlop, E. A and Tee, A. R. (2014)."mTOR and Autophagy: A Dynamic Relationship Governed by Nutrients and Energy", Seminars in Cell and Developmental Biology, PP. 1–9.
[11].Ravikumar, B., Sarkar, S. Davies, J. E., Futter, M., Garcia-arencibia, M., Green-thompson, Z. W., Jimenezsanchez, M., Korolchuk, V. I., Lichtenberg, M., Luo, S., Massey, D. C. O., Menzies, F. M., Moreau, K., Narayanan, U., Renna, M., Siddiqi, F. H., Underwood, B. R., Winslow, A. R., and Rubinsztein, D. C. (2010)."Regulation of Mammalian Autophagy in Physiology and Pathophysiology", Physiology Reviews, Vol. 90, PP. 1383–1435.
[12].Jung, C. H., Ro, S.-H., Cao, Otto, J. N. M. and Kim, D.-H. (2010 )."mTOR Regulation of Autophagy", FEBS Letters, Vol. 584, No. 7. PP. 1287–95.
[13].Jewell,J. L., Russell, R. C. and Guan, K.-L. (2013)."AminoAcidSignalling Upstream of Mtor", Nature Reviews Molecular Cell Biololgy, Vol. 14, No. 3. PP. 133–9.
[14].Nixon, R.A. (2013). "The Role of Autophagy in Neurodegenerative Disease", Nature Medicine, Vol. 19. PP. 983–97.
[15].Wong, M. (2012)."Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases", Biomedical Journal, Vol.36, No.2. PP. 40–50.
[16].Saxena, A. and Sampson, J. R. (2014). "Phenotypes Associated with Inherited and Developmental Somatic Mutations in Genes Encoding mTOR Pathway Components", Seminars in Cell and Developmental Biology. Vol. 36, PP. 140–6.
[17].Cornu, M., Albert, V. and Hall, M. N. (2013)."mTOR in Aging, Metabolism, and Cancer", Current Opinion in Genetics and Development, Vol. 23, No. 1. PP. 53–62.
[18].Leontieva,O. V, Paszkiewicz, G. M. and Blagosklonny, M. V. (2012). "Mechanistic or Mammalian Target of Rapamycin (mTOR) may Determine Robustness in Young male Mice at the Cost of Accelerated Aging", Aging, Vol. 4, No. 12. PP. 899–916.
[19].Blagosklonny, M. V (2010 ). "Calorie Restriction, Decelerating mTOR-Driven Aging from Cells to Organisma (including humans)", Landes Biosciences, Vol. 9, No. 4. PP. 683–688.
[20].Tor, R. O. S. and Blagosklonny, M. V (2008). "Aging ROS or TOR", Landes Biosciences, Vol. 7, No. 21. PP. 3344–3354.
[21]. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Clinton, M. Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Christy, S., Pahor, M., Javors, M. A., Fernandez, E. and Miller, R. A. (2009)."Rapamycin Fed Late in Life Extends Lifespan in Genetically Heterogeneous Mice". Nature, Vol. 460, No. 7253. PP. 392–395.